SOGC CLINICAL PRACTICE GUIDELINEToxoplasmosis in Pregnancy: Prevention, Screening, and Treatment
Section snippets
Recommendations
- 1.
Routine universal screening should not be performed for pregnant women at low risk. Serologic screening should be offered only to pregnant women considered to be at risk for primary Toxoplasma gondii infection. (II-3E)
- 2.
Suspected recent infection in a pregnant woman should be confirmed before intervention by having samples tested at a toxoplasmosis reference laboratory, using tests that are as accurate as possible and correctly interpreted. (II-2B)
- 3.
If acute infection is suspected, repeat testing
References (0)
Cited by (133)
Eudragit coated microemulsion for enhanced efficacy of spiramycin against toxoplasmic encephalitis
2022, Journal of Drug Delivery Science and TechnologyGenetic polymorphism of IL-17A (rs2275913) in Iraqi women with recurrent abortion and its relationship with susceptibility to toxoplasmosis
2021, Meta GeneCitation Excerpt :Toxoplasmosis is one of the most prevalent causes of abortion and congenital aberrations in infected women (Paquet et al., 2013).
Ultrasound diagnosis of infections in pregnancy
2021, European Journal of Obstetrics and Gynecology and Reproductive BiologyScreening for CMV and toxoplasmosis: An international comparison
2023, Gynakologie
This clinical practice guideline has been prepared by the Infectious Disease Committee, reviewed by the Family Practice Advisory Committee and the Maternal Fetal Medicine Committee, and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
Disclosure statements have been received from all members of the committee.
This document reflects emerging clinical and scientific advances on the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions. They should be well documented if modified at the local level. None of these contents may be reproduced in any form without prior written permission of the SOGC.